Clinical Trial Update: A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas [Phase 1]

View source ↗

Summary

Phase 1 multicenter trial assessing the safety and pharmacokinetics of intravenously infused berubicin in pediatric patients with progressive, refractory, or re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Berubicin (berubicin)

Snippet

Sponsor: WPD Pharmaceuticals Sp. z o.o. | Conditions: High Grade Glioma | Phase 1 | Status: WITHDRAWN